Risk estimation in this model is based on clinical deterioration, functional lung capacity, brain natriuretic peptide (BNP), or N-terminal-proBNP (NT-proBNP) concentrations, invasive hemodynamic variables, and echocardiographic evaluation of right atrial (RA) area and pericardial effusion. The gene discussed is NPPB; the disease is pericardial effusion.